Predictive Factors for Bone Complications in Prostate Cancer
Author Information
Author(s): Berruti A, Tucci M, Mosca A, Tarabuzzi R, Gorzegno G, Terrone C, Vana F, Lamanna G, Tampellini M, Porpiglia F, Angeli A, Scarpa R M, Dogliotti L
Primary Institution: Dipartimento di Scienze Cliniche e Biologiche Università degli Studi di Torino, Prostate Cancer Unit, Oncologia Medica, Urologia, Medicina Interna, Azienda Ospedaliera San Luigi, Orbassano, Italy
Hypothesis
What factors predict skeletal-related events in hormone-refractory prostate cancer patients with metastatic bone disease?
Conclusion
Bone pain and disease extent in bone independently predict the occurrence of skeletal-related events in hormone-refractory prostate cancer patients.
Supporting Evidence
- 43% of patients experienced skeletal-related events.
- Bone pain and disease extent in bone were significant predictors of skeletal-related events.
- Patients with high pain scores and extensive disease had a higher incidence of skeletal-related events.
Takeaway
Doctors can tell how likely it is for prostate cancer patients to have bone problems by looking at their pain and how much cancer is in their bones.
Methodology
The study evaluated 200 hormone-refractory prostate cancer patients for skeletal-related events using univariate and multivariate analyses.
Potential Biases
Potential bias due to the observational nature of the study and the exclusion of patients with prior treatments.
Limitations
The study may not account for all variables influencing skeletal-related events, and some data were only available for a subset of patients.
Participant Demographics
Median age of participants was 73 years, with a range from 52 to 92 years.
Statistical Information
P-Value
P=0.0001
Confidence Interval
95% CI: 1.07–1.25
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website